Wireless deep brain stimulation of well-defined neuronal populations could facilitate the study of intact brain circuits and the treatment of neurological disorders. Here, we demonstrate minimally invasive and remote neural excitation through the activation of the heat-sensitive capsaicin receptor TRPV1 by magnetic nanoparticles. When exposed to alternating magnetic fields, the nanoparticles dissipate heat generated by hysteresis, triggering widespread and reversible firing of TRPV1 + neurons. Wireless magnetothermal stimulation in the ventral tegmental area of mice evoked excitation in subpopulations of neurons in the targeted brain region and in structures receiving excitatory projections. The nanoparticles persisted in the brain for over a month, allowing for chronic stimulation without the need for implants and connectors. S timulation of deep brain structures affected by treatment-resistant psychiatric and neurological disorders can ameliorate associated symptoms but is currently only achieved by permanently implanted electrodes (1). Second-generation neuromodulation technologies rely on acoustic (2), electromagnetic induction (3), or optical (4) signals. These fields are largely absorbed and scattered by tissue and similarly require a conduit for deep brain stimulation. In contrast, low-radiofrequency alternating magnetic fields (100 kHz to 1 MHz) can penetrate into the body without substantial attenuation and thus enable signal delivery into deep brain regions (5). Alternating magnetic fields can be converted into biological stimuli by magnetic nanoparticles (MNPs) that dissipate heat via hysteretic power loss (6). Although MNP heating has been investigated as a cell-destructive therapy in magnetic hyperthermia for 50 years (7), this effect has only recently been exploited for control of cell membrane depolarization and gene expression in engineered xenografts and invertebrates (8, 9) . Magnetothermal control of neural activity in vivo in a mammalian system remains to be demonstrated.
S
timulation of deep brain structures affected by treatment-resistant psychiatric and neurological disorders can ameliorate associated symptoms but is currently only achieved by permanently implanted electrodes (1) . Second-generation neuromodulation technologies rely on acoustic (2), electromagnetic induction (3), or optical (4) signals. These fields are largely absorbed and scattered by tissue and similarly require a conduit for deep brain stimulation. In contrast, low-radiofrequency alternating magnetic fields (100 kHz to 1 MHz) can penetrate into the body without substantial attenuation and thus enable signal delivery into deep brain regions (5) . Alternating magnetic fields can be converted into biological stimuli by magnetic nanoparticles (MNPs) that dissipate heat via hysteretic power loss (6) . Although MNP heating has been investigated as a cell-destructive therapy in magnetic hyperthermia for 50 years (7) , this effect has only recently been exploited for control of cell membrane depolarization and gene expression in engineered xenografts and invertebrates (8, 9) . Magnetothermal control of neural activity in vivo in a mammalian system remains to be demonstrated.
To achieve reversible neuronal activation with alternating magnetic fields, we developed an intracellular calcium control scheme by sensitizing cells to heat generated from MNPs (Fig. 1A) . Earlier experiments relied on synthetic transgenes to target MNPs to the cell membrane and required tens to thousands of seconds to observe increased calcium ion (Ca 2+ ) influx, which exceeded temporal dynamics of neuronal firing by orders of magnitude. Recent studies suggest that MNP functionalization with proteins induces cell internalization and the formation of protein coronas that may reduce the effectiveness of targeting and heat dissipation in vivo (10, 11 (17), we designed a transgene to establish sustained and uniform levels of TRPV1 expression for magnetothermal membrane depolarization across different cell lines (18) . The TRPV1 transgene was placed under the excitatory neuronal promoter calmodulin kinase II a-subunit along with mCherry separated from TRPV1 by the posttranscriptional cleavage linker p2A (CamKIIa::TRPV1-p2A-mCherry) (19) and packed into the lentiviral vector so as to enable longterm in vitro and in vivo neural transfection (20) . Cells were additionally transfected with the adeno-associated virus serotype 9 (AAV9) carrying GCaMP6s under the neuronal promoter human synapsin (hSyn::GCaMP6s) for measurement of intracellular Ca 2+ changes as a proxy for membrane depolarization (21) . Functionality of the two genes was confirmed by observing increased fluorescence intensity in response to capsaicin, a TRPV1 agonist, and temperature increase above 43°C in nonexcitable HEK293FT cells ( fig. S4 , A to C).
We first demonstrated magnetothermal control of intracellular Ca 2+ influx in HEK293FT cells. Fluorescence intensity maps indicated that only cells expressing TRPV1 (TRPV1 + ) responded to the field stimulus ( ƒ = 500kHz, H o = 15 kA/m) when incubated in MNP solutions (2 mg/mL), whereas cells not expressing TRPV1 (TRPV1 -) as well as TRPV1 + and TRPV1 -cells without field stimulus did not exhibit changes in intracellular Ca 2+ concentration (Fig. 1E) . A field-induced temperature increase in excess of 43°C in MNP solutions triggered a GCaMP6s fluorescence increase of D F/F 0 > 50% in 36.1 T 4.3% (mean T SD) of TRPV1 + cells, whereas only 1.7 T 1.6% (mean T SD) of TRPV1 -cells exhibited a similar response ( Fig. 1F and fig. S5 , A to D). Magnetothermal membrane depolarization was sufficient to evoke trains of action potentials in primary hippocampal neurons expressing TRPV1 when exposed to 10-s field pulses at 60-s intervals. Viral transfection with AAV9-hSyn::GCaMP6s, which allows for fluorescence detection of single action potential events (21) , and Lenti-CamKIIa:: TRPV1-p2A-mCherry (TRPV1 + ) or Lenti-CamKIIa:: mCherry (TRPV1 -) yielded a coexpression efficiency of 57% after 5 days ( Fig. 2A) . In MNP solutions (10 mg/ml), 85 T 14% of TRPV1 + neurons exhibited synchronized firing within 5 s after stimulus, whereas only sporadic activity was observed in TRPV1 -neurons (Fig. 2, B to   H ). This implies that the temperature increase ( Fig. 2D ) in MNP solutions exposed to alternating magnetic field was sufficient to trigger TRPV1 (Fig. 2H ) while avoiding nonspecific thermal effects such as changes in membrane capacitance (Fig. 2F ) (22) . In the absence of MNPs, magnetic field did not induce appreciable solution heating (Fig. 2C) , and no correlated response was observed in TRPV1 + or TRPV1 -neurons (Fig. 2, B , E, and G). We recorded neural activity from GCaMP6s temporal fluorescence traces ( fig. S6 , A to D, and movie S1) (23) . Waves of Ca 2+ spikes were repeatedly induced by field pulses only in TRPV1 + neurons in the presence of MNPs (Fig. 2, I to P). The observed 5-s latency between the field application and the onset of neural activity is fivefold faster than previously described (8) .
We next tested whether alternating magnetic field could activate a subpopulation of neurons in deep brain tissue in mice. We used finite element modeling corroborated with temperature recordings in brain phantoms to predict local temperature changes in response to field stimulus ( fig. S7 ). Injections (2.5 mL) of MNP solution (100 mg/mL) delivered temperature gradients sufficient to reach the TRPV1 activation threshold within 5 s and cool back to 37°C over 60-s cycles ( fig. S7 , B to F), thus avoiding prolonged exposure to noxious heat ( fig. S7G) (24) .
With low endogenous expression of TRPV1 (25) and well-characterized projections (26), the ventral tegmental area (VTA) was an attractive deep brain target for initial demonstration of magnetothermal stimulation. Furthermore, phasic excitation in the VTA has therapeutic implications in the treatment of major depression (27) . We sensitized excitatory neurons in the VTA to heat through the lentiviral delivery of TRPV1, which was followed by MNP injection into the same region 4 weeks later (Fig. 3, A  and B, and fig. S8A ). The anesthetized mice were exposed to the magnetic field conditions described above ( fig. S8 , B and C). Neuronal excitation was quantified by the extent of activitydependent expression of the immediate early gene c-fos within a 250-mm vicinity of the MNP injection (Fig. 3, C to F) (28) . Neural activity was only triggered by magnetic field in the VTA of mice transfected with TRPV1 in the presence of MNPs, resulting in a significantly higher proportion of c-fos-positive (c-fos + ) cells, as revealed by a two-way analysis of variance (ANOVA) with a Bonferroni post hoc test (F 1,13 =47.5, P < 0.0001) (Fig. 3G) . Control subjects testing whether the MNP injection, heat dissipation with field stimulus, or TRPV1 expression alone can result in neural stimulation showed no significant c-fos expression (Fig. 3, C to E and G) . Furthermore, the spatial extent of neuronal activation was largely collocated with TRPV1 expression in the VTA (Fig. 3, H and I) .
We next investigated whether neurons in the VTA can be activated 1 month after MNP injection so as to explore its chronic utility (Fig. 3, J to O). We again observed increased c-fos expression in the VTA only in mice transfected with TRPV1 in the presence of MNPs and exposed to the magnetic field protocol described above (Fig. 3, J and M, "ON" ) (Student's t test, P < 0.02). In these mice, we also found evidence of field-evoked up-regulation of c-fos in the medial prefrontal cortex (mPFC) (Fig. 3 , K and N, "ON") (Student's t test, P < 0.02) and nucleus accumbens (NAc) (Fig. 3 , L and O, "ON") (Student's t test, P < 0.002), which are known to receive excitatory inputs from VTA neurons (26, 29) . In the absence of stimulation, neurons in the VTA near the MNP injection site and the neurons in the mPFC and NAc did not exhibit increased c-fos expression (Fig. 3 , J to O, "OFF").
We compared the biocompatibility of the MNP injection with a similarly sized stainless steel implant ( fig. S9) . The interface between the MNP injection and the tissue exhibited significantly lower glial activation and macrophage accumulation and higher proportion of neurons, as compared with that of the steel implant 1 week and 1 month after surgery ( fig. S9, A to F) . The improved tissue compatibility can likely be attributed to the mechanically pliable nature of the MNP injection and sequestration via endocytosis (12, 13) . No difference in neuronal or glial density was observed between brain tissue of stimulated and unstimulated mice, suggesting that the rapidly dissipated magnetothermal cycles cause minimal thermal damage to the surrounding tissue ( fig. S9G) .
We demonstrated widespread and repeatable control of cellular signaling in nonexcitable and electroactive cells using wireless magnetothermal stimulation in vitro and in vivo. Finer control over stimulation intensity to facilitate applications of this approach to problems in systems neuroscience can be achieved by further reducing the latency between field onset and evoked neural firing by developing MNPs with high specific loss powers (30) and by introducing heat-sensitive ion channels with lower thermal thresholds (31) . Mechanosensitive potassium and chloride channels may serve as potential mediators of magnetothermal inhibition (32) . Although demonstrated for chronic stimulation of targeted neural circuits, this magnetothermal paradigm may be formulated to trigger thermosensitive ion channels endogenously expressed in the peripheral nervous system (17) , enabling wireless control in deep tissue regions that currently pose substantial challenges to bioelectronic medicines (33 The literature has been contradictory regarding whether parents who were abused as children have a greater tendency to abuse their own children. A prospective 30-year follow-up study interviewed individuals with documented histories of childhood abuse and neglect and matched comparisons and a subset of their children. The study assessed maltreatment based on child protective service (CPS) agency records and reports by parents, nonparents, and offspring. The extent of the intergenerational transmission of abuse and neglect depended in large part on the source of the information used. Individuals with histories of childhood abuse and neglect have higher rates of being reported to CPS for child maltreatment but do not self-report more physical and sexual abuse than matched comparisons. Offspring of parents with histories of childhood abuse and neglect are more likely to report sexual abuse and neglect and that CPS was concerned about them at some point in their lives. The strongest evidence for the intergenerational transmission of maltreatment indicates that offspring are at risk for childhood neglect and sexual abuse, but detection or surveillance bias may account for the greater likelihood of CPS reports.
F
or years, the notion that abused children grow up to become abusive parents has been widely accepted in the field of child abuse and neglect (1) (2) (3) . However, because many other factors in a person's life (such as natural abilities, biological or genetic predispositions, or intervening relationships) may mediate the effects of child abuse and neglect, assessing the intergenerational transmission of abuse and neglect is challenging. Although some studies have provided empirical support for the intergenerational transmission of child abuse (4-10),
